Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14879056 | 0.74 | — | — | |
| SCHEMBL11183863 | 0.71 | MEN1 (0.39) | MEN1ALDH1A1KMT2ATDP1 | |
| SCHEMBL11505140 | 0.68 | — | — | |
| SCHEMBL6902013 | 0.68 | MEN1 (0.35) | MEN1ALDH1A1KMT2ATDP1 | |
| SCHEMBL16553540 | 0.66 | ERN1 (0.32) | — | |
| SCHEMBL9054283 | 0.65 | ERN1 (0.31) | — | |
| SCHEMBL6902686 | 0.63 | ALDH1A1 (0.48) | MEN1ALDH1A1KMT2ATDP1 | |
| SCHEMBL6903290 | 0.63 | ERN1 (0.50) | MEN1ALDH1A1KMT2ATDP1 | |
| SCHEMBL23121444 | 0.58 | MEN1 (0.32) | MEN1ALDH1A1KMT2ATDP1 | |
| SCHEMBL21643711 | 0.58 | MEN1 (0.45) | MEN1ALDH1A1KMT2ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7355067-B2 | Process for the production of triiodotrimesic acid | SCHERING AG (DE) | 2008-04-08 | — | — | US | disclosed |
| US-7355067-B2 | Process for the production of triiodotrimesic acid | SCHERING AG (DE) | 2008-04-08 | — | — | US | disclosed |
| US-20070093674-A1 | Process for the production of triiodotrimesic acid | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2007-04-26 | — | — | US | disclosed |
| US-20070093674-A1 | Process for the production of triiodotrimesic acid | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2007-04-26 | — | — | US | disclosed |
| US-7166740-B2 | Process for the production of triiodotrimesic acid | SCHERING AG (DE) | 2007-01-23 | — | — | US | disclosed |
| US-7166740-B2 | Process for the production of triiodotrimesic acid | SCHERING AG (DE) | 2007-01-23 | — | — | US | disclosed |
| US-6448442-B1 | X-RAY CONTRAST AGENTS; LOW VISCOSITY IODINATED ARYL COMPOUNDS | AMERSHAM HEALTH AS (NO) | 2002-09-10 | — | — | US | disclosed |
| US-6310243-B1 | BENZENE COMPOUNDS IN WHICH 3 NON-ADJACENT RING ATOMS ARE SUBSTITUTED WITH IODINE, 2 OF THE REMAINING RING ATOMS ARE AMIDE SUBSTITUTED WITH HYDROXY AND THE OTHER REMAINING RING ATOM IS A NON-AMIDE, HYDROXY-SUBSTITUTED NONIONIC MOIETY | NYCOMED IMAGING AS (NO) | 2001-10-30 | — | — | US | disclosed |
| US-5993780-A | A POLYIODOARYLALKYL ALCOHOL OR DERIVATIVE | NYCOMED IMAGING AS (NO) | 1999-11-30 | — | — | US | disclosed |
| EP-0782564-B1 | IODINATED X-RAY CONTRAST MEDIA | NYCOMED IMAGING AS (NO) | 1999-09-01 | — | — | EP | disclosed |
| US-5882628-A | Contrast media | NYCOMED IMAGING AS (NO) | 1999-03-16 | — | — | US | disclosed |
| EP-0782564-A1 | IODINATED X-RAY CONTRAST MEDIA | NYCOMED IMAGING AS (NO) | 1997-07-09 | — | — | EP | disclosed |
| WO-1996009282-A1 | IODINATED X-RAY CONTRAST MEDIA | NYCOMED IMAGING A/S (NO) | 1996-03-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070093674-A1 | Process for the production of triiodotrimesic acid | TRHDE, TRHR, TSHR | MEN1 50/4885ALDH1A1 3838/4885KMT2A 2521/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.